mesylate


Also found in: Dictionary, Encyclopedia, Wikipedia.
Related to mesylate: Imatinib mesylate, eprosartan mesylate, Gemifloxacin mesylate, Bromocriptine mesylate

mesylate

 [mes´ĭ-lāt]
USAN contraction for methanesulfonate.

mesylate

/mes·y·late/ (mes´ĭ-lāt) USAN contraction for methanesulfonate.

mesylate

(mĕs′ə-lāt′)
n.
A salt, ester, or anion of methanesulfonic acid. Also called methanesulfonate.
References in periodicals archive ?
17, 2002, Imatinib Mesylate has developed fast with annual sales reaching CNY 532 million in 2014 and CAGR reaching up to 42% during the period of 2005- 2014.
Therefore, phentolamine mesylate has not been tested for efficacy following use of local anesthetic without added vasoconstrictors.
Saquinavir mesylate (Fortovase [soft gel capsule], Invirase [hard gel capsule], SQV), Hoffmann-La Roche
Deferoxamine Mesylate is an iron chelating agent that is used for iron poisoning as well as chronic iron overload due to transfusion-dependent anemias.
Breckenridge's dabigatran etexilate mesylate product is a continuing part of its larger effort to bring products to market in conjunction with its parent company, Pensa Dose and the Esteve Group.
The anti-tumour activity of eribulin mesylate, as observed in this study, is encouraging, given the limited treatment options for women with advanced breast cancer who have previously received multiple lines of therapy," said lead investigator Linda T.
When dripped into guinea pigs' spinal fluid via a small pump implanted under each animal's skin, imatinib mesylate suppressed the formation of amyloid-beta-peptide plaques in the guinea pigs' brains, says William J.
How imatinib mesylate might induce hair repigmentation is a mystery," the researchers concluded (N.
A Phase III, open-label, randomized, multicenter study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with anthracyclines and taxanes
The chief problem with deferoxamine mesylate therapy is that patients sometimes skip treatments, notes Stanley L.
today announced that its New Drug Application (NDA) for low-dose mesylate salt of paroxetine (LDMP; 7.